| Literature DB >> 35212166 |
Yunfeng Bi1,2, Jianjun Liu3, Mingbiao Ma1, Lvyan Tao1, Yun Peng1, Xiting Dai1, Zhenhua Ji1, Ruolan Bai1, Miaomiao Jian1, Taigui Chen1, Lisha Luo1, Feng Wang1, Zhe Ding1, Aihua Liu1, Fukai Bao1.
Abstract
The zoonotic Lyme neuroborreliosis (LNB) disease is caused by Borrelia burgdorferi, with wide distribution, rapid dissemination and high disability rate. However, the molecular mechanism underlying B. burgdorferi mediated neuroborreliosis remains largely unknown. Here, the frontal cortex from rhesus brains was incubated with B. burgdorferi, and proteomics profiling was evaluated by isobaric tag for relative and absolute quantitation. Proteins were identified and quantified, and differentially expressed proteins (DEPs) were isolated by comparing co-cultured samples and control samples. A total of 43, 164 and 368 DEPs were significantly altered after 6, 12 and 24 h treatment with B. burgdorferi respectively. Gene ontology and KEGG pathway analyses revealed that chemokine biological process was significantly enriched. Two genes in chemokine pathway including GRB2 and ROCK2 were significantly up-regulated after B. burgdorferi co-culturing. By in vitro assay, we confirmed that the expression of GRB2 and ROCK2 was increased after B. burgdorferi infection. In conclusion, our study revealed the involvement of chemokine pathway in the pathogenesis of LNB. GRB2 and ROCK2 may be novel biomarkers and therapeutic targets for LNB.Entities:
Keywords: zzm321990Borrelia burgdorferizzm321990; GRB2; Lyme neuroborreliosis; ROCK2; chemokine pathway; proteomics
Mesh:
Substances:
Year: 2022 PMID: 35212166 PMCID: PMC8995463 DOI: 10.1111/jcmm.17253
Source DB: PubMed Journal: J Cell Mol Med ISSN: 1582-1838 Impact factor: 5.295
iTRAQ labelling
| Sample ID | Batch ID | Label ID |
|---|---|---|
| P_6h−1 | Batch 1 | 113 |
| Bb_6h−1 | 114 | |
| P_12h−1 | 115 | |
| Bb_12h−1 | 116 | |
| P_24h−1 | 117 | |
| Bb_24h−1 | 118 | |
| P_6h−2 | Batch 2 | 113 |
| Bb_6h−2 | 114 | |
| P_12h−2 | 115 | |
| Bb_12h−2 | 116 | |
| P_24h−2 | 117 | |
| Bb_24h−2 | 118 |
Parameters for Protein pilot search
| Item | Value |
|---|---|
| Type of search | iTRAQ 8‐plex (Peptide Labelled) |
| Enzyme | Trypsin |
| Cys alkylation | Iodoacetamide |
| Instrument | TripleTOF 5600 |
| Bias correction | TRUE |
| Background correction | TRUE |
| ID focus | Biological modifications |
| Search effort | Thorough ID |
| Protein mass | Unrestricted |
| Database | Uniprot Macacamulatta20171231.fasta (45,199 items) |
FIGURE 1Overview of experimental design, analytical strategy and data assessment. (A) Sections of Rhesus frontal cortex were co‐cultured with Bb in vitro. Control group was set by culturing frontal cortex with RPMI 1640 medium supplemented with 10% FBS. Samples were harvested after 6, 12 and 24 h of co‐culturing. Proteins were extracted for iTRAQ. Protein identification and quantification were determined with ProteinPilot software. Differentially expressed proteins (DEPs) and related biological pathways were identified. (B) Distribution of the number of proteins with different number of unique peptides. (C) Length distribution of peptide segment. (D) Pie plot showing the different percentage of protein coverage distribution
FIGURE 2GO analyses of DEPs at different time points after co‐culture. (A) At 6 h after co‐culture, DEPs were significantly enriched in viral infection related pathways, necrotic cell death and oxoacide metabolic process biological pathways. (B) At 12 h after co‐culture, biological pathways such as oxidation reduction, programmed cell death, apoptosis and DNA checkpoint were significantly enriched. (C) At 24 h after co‐culture, oxidative phosphorylation, programmed cell death, necrotic cell death and chemotaxis biological pathways were significantly enriched for DEPs
FIGURE 3KEGG analyses of DEPs at different time points after co‐culture. (A) At 6 h after co‐culture, ribosome, endocytosis, viral myocarditis and folate biosynthesis pathways were significantly enriched. (B) At 12 h after co‐culture, neurodegenerative disorders including Parkinson's disease, Huntington's disease, Alzheimer's disease were enriched. Oxidative phosphorylation and Wnt signalling pathway were also enriched. (C) B. At 24 h after co‐culture, neurodegenerative diseases pathways, oxidative phosphorylation and chemokine signalling pathway were enriched
Changes of expression of the proteins in chemokine pathway
| Protein name | 6 h | 12 h | 24 h |
|---|---|---|---|
| FC and | FC and | FC and | |
| AC | 0.941 | 1.010 | 1.067 |
| 0.579 | 0.874 | 0.258 | |
| Akt | 0.934 | 0.533 | 1.570 |
| 0.403 | 0.060 | 0.346 | |
| Cdc42 | 1.014 | 0.537 | 1.770 |
| 0.742 | 0.133 | 0.780 | |
| CrK | 0.830 | 1.793 | 1.295 |
| 0.417 | 0.230 | 0.068 | |
| CSK | 1.132 | 0.636 | 0.626 |
| 0.988 | 0.396 | 0.504 | |
| ERK1 | 1.065 | 1.240 | 3.294 |
| 0.584 | 0.344 | 0.101 | |
| Gαi | 1.043 | 1.433 | 11.262 |
| 0.323 | 0.049 | 0.034 | |
| Gβγ | 2.260 | 1.686 | 2.871 |
| 0.287 | 0.073 | 0.008 | |
| GRB2 | 1.003 | 0.526 | 9.810 |
| 1.000 | 0.028 | 0.024 | |
| GRK | 1.065 | 1.170 | 0.934 |
| 0.584 | 0.556 | 0.735 | |
| GSK3B | 1.122 | 0.677 | 0.671 |
| 0.651 | 0.445 | 0.213 | |
| IKK | 0.801 | 1.110 | 0.634 |
| 0.235 | 0.940 | 0.126 | |
| MAPK3 | 1.083 | 0.906 | 0.671 |
| 0.366 | 0.551 | 0.254 | |
| PAK1 | 1.189 | 0.916 | 0.946 |
| 0.245 | 0.164 | 0.647 | |
| PI3K | 1.220 | 1.107 | 0.598 |
| 0.131 | 0.870 | 0.324 | |
| PKA | 1.087 | 1.057 | 1.108 |
| 0.205 | 0.205 | 0.318 | |
| PKC | 0.871 | 2.006 | 2.681 |
| 0.623 | 0.029 | 0.111 | |
| PLCβ | 0.820 | 1.249 | 7.949 |
| 0.044 | 0.156 | 0.011 | |
| PTK2B | 0.834 | 0.733 | 0.649 |
| 0.371 | 0.349 | 0.282 | |
| Rac | 1.507 | 0.682 | 0.484 |
| 0.156 | 0.023 | 0.203 | |
| Raf | 0.863 | 1.672 | 0.921 |
| 0.607 | 0.253 | 0.671 | |
| Rap1 | 0.756 | 0.383 | 0.418 |
| 0.472 | 0.194 | 0.332 | |
| RhoA | 1.194 | 0.563 | 0.428 |
| 0.534 | 0.036 | 0.111 | |
| ROCK | 0.943 | 1.570 | 4.018 |
| 0.782 | 0.136 | 0.044 | |
| SOS | 0.962 | 0.853 | 0.710 |
| 0.821 | 0.258 | 0.126 | |
| WASP | 0.646 | 0.803 | 0.618 |
| 0.197 | 0.573 | 0.482 | |
| β‐arrestin | 0.852 | 0.959 | 1.011 |
| 0.444 | 0.070 | 0.895 |
The proteins in Bb group were up‐regulated by >1.2) and down‐regulated by <0.83, compared with control group. For p < 0.05, the expression of protein in Bb group was regarded as significantly different. The differences between two batches were averaged.
FIGURE 4PPI network and expression analysis of ROCK2 and GRB2. (A) PPI network analysis of GRB2 and ROCK2. (B) Western blot analysis of ROCK2 and GRB2 after 6, 12 and 24 h of Bb infection. Shown were representative bolts from three independent experiments with new samples. (C) Densitometry analysis of ROCK2 protein levels. *p < 0.05, **p < 0.01, ***p < 0.001. N = 3. (D) Densitometry analysis of GRB2 protein levels. ns: not significant, *p < 0.05; **p < 0.01. N = 3. E. Real‐time PCR analysis of GRB2 and ROCK2 mRNA levels after 6, 12 and 24 h of Bb infection. Data were from three independent experiments with new samples. **p < 0.01, ***p < 0.001. N = 3